Mechanisms underlying atrial-selective block of sodium channels by Wenxin Keli: Experimental and theoretical analysis
- PMID: 26820362
- PMCID: PMC4758862
- DOI: 10.1016/j.ijcard.2016.01.016
Mechanisms underlying atrial-selective block of sodium channels by Wenxin Keli: Experimental and theoretical analysis
Abstract
Introduction: Atrial-selective inhibition of cardiac sodium channel current (INa) and INa-dependent parameters has been shown to contribute to the safe and effective management of atrial fibrillation. The present study was designed to examine the basis for the atrial-selective actions of Wenxin Keli.
Methods: Whole cell INa was recorded at room temperature in canine atrial and ventricular myocytes. Trains of 40 pulses were elicited over a range of pulse durations and interpulse intervals to determine tonic and use-dependent block. A Markovian model for INa that incorporates interaction of Wenxin Keli with different states of the channel was developed to examine the basis for atrial selectivity of the drug.
Results: Our data indicate that Wenxin Keli does not bind significantly to either closed or open states of the sodium channel, but binds very rapidly to the inactivated state of the channel and dissociates rapidly from the closed state. Action potentials recorded from atrial and ventricular preparations in the presence of 5g/L Wenxin Keli were introduced into the computer model in current clamp mode to simulate the effects on maximum upstroke velocity (Vmax). The model predicted much greater inhibition of Vmax in atrial vs. ventricular cells at rapid stimulation rates.
Conclusion: Our findings suggest that atrial selectivity of Wenxin Keli to block INa is due to more negative steady-state inactivation, less negative resting membrane potential, and shorter diastolic intervals in atrial vs. ventricular cells at rapid activation rates. These actions of Wenxin Keli account for its relatively safe and effective suppression of atrial fibrillation.
Keywords: Antiarrhythmic drugs; Arrhythmias; Atria; Electrophysiology; Pharmacology; Ventricles.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.
Figures
Similar articles
-
Therapeutic Effects of Wenxin Keli in Cardiovascular Diseases: An Experimental and Mechanism Overview.Front Pharmacol. 2018 Sep 5;9:1005. doi: 10.3389/fphar.2018.01005. eCollection 2018. Front Pharmacol. 2018. PMID: 30233380 Free PMC article. Review.
-
Atrial-selective inhibition of sodium-channel current by Wenxin Keli is effective in suppressing atrial fibrillation.Heart Rhythm. 2012 Jan;9(1):125-31. doi: 10.1016/j.hrthm.2011.08.027. Epub 2011 Aug 30. Heart Rhythm. 2012. PMID: 21884675 Free PMC article.
-
Inhibition of IKr potentiates development of atrial-selective INa block leading to effective suppression of atrial fibrillation.Heart Rhythm. 2015 Apr;12(4):836-44. doi: 10.1016/j.hrthm.2014.12.033. Epub 2014 Dec 26. Heart Rhythm. 2015. PMID: 25546810
-
Wenxin Keli suppresses ventricular triggered arrhythmias via selective inhibition of late sodium current.Pacing Clin Electrophysiol. 2013 Jun;36(6):732-40. doi: 10.1111/pace.12109. Epub 2013 Feb 25. Pacing Clin Electrophysiol. 2013. PMID: 23438075
-
Late INa Inhibition as an Antiarrhythmic Strategy.J Cardiovasc Pharmacol. 2017 Sep;70(3):159-167. doi: 10.1097/FJC.0000000000000510. J Cardiovasc Pharmacol. 2017. PMID: 28654510 Review.
Cited by
-
Efficacy of Wenxin Keli Plus Amiodarone versus Amiodarone Monotherapy in Treating Recent-Onset Atrial Fibrillation.Cardiol Res Pract. 2018 Dec 4;2018:6047271. doi: 10.1155/2018/6047271. eCollection 2018. Cardiol Res Pract. 2018. PMID: 30622821 Free PMC article.
-
Therapeutic Effects of Wenxin Keli in Cardiovascular Diseases: An Experimental and Mechanism Overview.Front Pharmacol. 2018 Sep 5;9:1005. doi: 10.3389/fphar.2018.01005. eCollection 2018. Front Pharmacol. 2018. PMID: 30233380 Free PMC article. Review.
-
Wenxin Granules Regulate Endoplasmic Reticulum Stress Unfolded Protein Response and Improve Ventricular Remodeling on Rats with Myocardial Infarction.Evid Based Complement Alternat Med. 2021 Nov 2;2021:7375549. doi: 10.1155/2021/7375549. eCollection 2021. Evid Based Complement Alternat Med. 2021. PMID: 34765006 Free PMC article.
-
An Overview of Systematic Reviews on the Effectiveness of Wenxin Keli in the Treatment of Atrial Fibrillation.Evid Based Complement Alternat Med. 2022 May 30;2022:6973151. doi: 10.1155/2022/6973151. eCollection 2022. Evid Based Complement Alternat Med. 2022. PMID: 35677364 Free PMC article.
-
Wenxin Keli Regulates Mitochondrial Oxidative Stress and Homeostasis and Improves Atrial Remodeling in Diabetic Rats.Oxid Med Cell Longev. 2020 Feb 13;2020:2468031. doi: 10.1155/2020/2468031. eCollection 2020. Oxid Med Cell Longev. 2020. PMID: 32104528 Free PMC article.
References
-
- Burashnikov A, Di Diego JM, Zygmunt AC, Belardinelli L, Antzelevitch C. Atrium-selective sodium channel block as a strategy for suppression of atrial fibrillation: differences in sodium channel inactivation between atria and ventricles and the role of ranolazine. Circulation. 2007;116:1449–57. - PMC - PubMed
-
- Nattel S, Kneller J, Zou R, Leon LJ. Mechanisms of termination of atrial fibrillation by Class I antiarrhythmic drugs: evidence from clinical, experimental, and mathematical modeling studies. J CardiovascElectrophysiol. 2003;14:S133–S9. - PubMed
-
- Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, et al. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Am J Cardiol. 2003;91:15D–26D. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
